Bibliography:

  1. ‘psychiatry’ tag

  2. Political Fundraisers WinRed and ActBlue Are Taking Millions of Dollars in Donations from Elderly Dementia Patients to Fuel Their Campaigns

  3. Why Do Obesity Drugs Seem to Treat so Many Other Ailments?

  4. The Rise of the Science Sleuths

  5. 5b600ff68dbb1deea29966ec8e1f33dde31b75cb.html

  6. Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice

  7. Differences in early life cognitive function explain the association between low education and early dementia risk

  8. Trial of Lixisenatide in Early Parkinson’s Disease

  9. Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer’s Disease

  10. Lee Holloway: The Devastating Decline of a Brilliant Young Coder

  11. Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial

  12. The Vanishing Family: They all have a 50-50 chance of inheriting a cruel genetic mutation—which means disappearing into dementia in middle age. This is the story of what it’s like to live with those odds

  13. Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK, GRB14, and KIAA0825 as novel risk loci for Alzheimer disease: the Alzheimer Disease Genetics Consortium

  14. I lost 40 pounds on Ozempic. But I’m left with even more questions.

  15. Causal evidence that herpes zoster vaccination prevents a proportion of dementia cases

  16. Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy

  17. Association between hearing aid use and all-cause and cause-specific dementia: an analysis of the UK Biobank cohort

  18. Virus exposure and neurodegenerative disease risk across national biobanks

  19. The APOE locus is linked to decline in general cognitive function: 20-years follow-up in the Doetinchem Cohort Study

  20. Data Descriptor: Human whole exome genotype data for Alzheimer’s Disease

  21. Association of Whole-Person Eigen-Polygenic Risk Scores with Alzheimer’s Disease

  22. Lithium in drinking water and Alzheimer’s dementia: Epidemiological Findings from National Data Base of Japan

  23. What does heritability of Alzheimer’s disease represent?

  24. Cognitive Functioning of Unaffected First-degree Relatives of Individuals With Late-onset Alzheimer’s Disease: A Systematic Literature Review and Meta-analysis

  25. Evaluation of Transfer Learning Methods for Detecting Alzheimer’s Disease with Brain MRI

  26. White matter hyperintensities in former American football players

  27. Genetic architecture of the white matter connectome of the human brain

  28. Polygenic risk score as a possible tool for identifying familial monogenic causes of complex diseases

  29. Reduced dementia incidence after varicella zoster vaccination in Wales 2013–2020

  30. New insights into the genetic etiology of Alzheimer’s disease and related dementias

  31. Genome-wide association study of occupational attainment as a proxy for cognitive reserve

  32. Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brain

  33. Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers

  34. Multi-ancestry eQTL meta-analysis of human brain identifies candidate causal variants for brain-related traits

  35. Identifying imaging genetic associations via regional morphometricity estimation

  36. Evolution of Human-specific Alleles Protecting Cognitive Function of Grandmothers

  37. Genome-wide association study of cerebellar volume

  38. Rare Variant Aggregation in 148,508 Exomes Identifies Genes Associated with Proxy Alzheimer’s Disease

  39. The potential role of glial cells in driving the prion-like transcellular propagation of tau in tauopathies

  40. The viral hypothesis: how herpesviruses may contribute to Alzheimer’s disease

  41. An expanded set of genome-wide association studies of brain imaging phenotypes in UK Biobank

  42. Microglia use TAM receptors to detect and engulf amyloid β plaques

  43. Rare Genetic Variation Underlying Human Diseases and Traits: Results from 200,000 Individuals in the UK Biobank

  44. Largest GWAS (n = 1,126,563) of Alzheimer’s Disease Implicates Microglia and Immune Cells

  45. Glymphatic failure as a final common pathway to dementia

  46. Amyloid, tau and risk of Alzheimer’s disease: a Mendelian Randomization study

  47. Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis

  48. Disentangling selection on genetically correlated polygenic traits using whole-genome genealogies

  49. Computing Univariate Neurodegenerative Biomarkers with Volumetric Optimal Transportation: A Pilot Study

  50. The Multiplex Model of the Genetics of Alzheimer’s Disease

  51. Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers

  52. Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration

  53. FDA approves first oral GLP-1 treatment for type 2 diabetes

  54. The maddening saga of how an Alzheimer’s ‘cabal’ thwarted progress toward a cure for decades

  55. Towards Clinical Utility of Polygenic Risk Scores

  56. The Advantages of Bilingualism Debate

  57. Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan

  58. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence

  59. Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy

  60. Polygenic risk scores applied to a single cohort reveal pleiotropy among hundreds of human phenotypes

  61. Identifying genetic variants that affect viability in large cohorts

  62. Morphometricity as a measure of the neuroanatomical signature of a trait

  63. Genome-wide association study of cognitive functions and educational attainment in UK Biobank (n = 112 151)

  64. Shared genetic aetiology between cognitive functions and physical and mental health in UK Biobank (n = 112,151) and 24 GWAS consortia

  65. Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N = 53,949)

  66. Common polygenic variation enhances risk prediction for Alzheimer’s disease

  67. Standard and trace-dose lithium: A systematic review of dementia prevention and other behavioral benefits

  68. Evaluation of Excess Statistical-Significance Bias in Animal Studies of Neurological Diseases

  69. Terminal dedifferentiation of cognitive abilities

  70. Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis

  71. Most reported genetic associations with general intelligence are probably false positives

  72. How citation distortions create unfounded authority: analysis of a citation network

  73. Lithium Trial in Alzheimer’s Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study

  74. Lithium May Be Useful in the Prevention of Alzheimer’s Disease in Individuals at Risk of Presenile Familial Alzheimer’s Disease

  75. Temporal Cortex Direct Current Stimulation Enhances Performance on a Visual Recognition Memory Task in Alzheimer Disease

  76. A Feasibility and Tolerability Study of Lithium in Alzheimer’s Disease

  77. Prevalence of cognitive impairment without dementia in the United States

  78. Smoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies

  79. Lithium and Risk for Alzheimer’s Disease in Elderly Patients With Bipolar Disorder

  80. 0ed6c11c63268381a76ec487653cf262708acd8b.html

  81. Global prevalence of dementia: a Delphi consensus study

  82. Bayesian Value-Of-Information Analysis: an Application to a Policy Model of Alzheimer’s Disease

  83. f4d56910523d9e0b0dc0b7785c310c1264038377.pdf

  84. Worldwide Prevalence and Incidence of Dementia

  85. Aluminum as a Cause of Senile Dementia

  86. Dietary Aluminum and Alzheimer’s Disease

  87. Associations of Semaglutide With First-Time Diagnosis of Alzheimer’s Disease in Patients With Type 2 Diabetes: Target Trial Emulation Using Nationwide Real-World Data in the US

  88. The Alzheimer Photo

  89. Lithium’s Potential Role in Preventing Alzheimer’s Disease

  90. 90227d4612295a3a485de44a193a69ed3640bf17.html

  91. Digital Biomarkers for Alzheimer’s Disease: the Mobile/wearable Devices Opportunity

  92. The Woman Who Could Smell Parkinson’s

  93. The Academic Culture of Fraud

  94. 12-Month Neurological and Psychiatric Outcomes of Semaglutide Use for Type 2 Diabetes: a Propensity-Score Matched Cohort Study

  95. Why Do Humans Still Have a Gene That Increases the Risk of Alzheimer’s?

  96. 2023-eyting-figure1a-discontinuityinvaccineuse.jpg

  97. 2023-eyting-figure2-regressiondiscontinuityofvaccineondementiadiagnosis.jpg

  98. 2017-mukadam.pdf

  99. 2016-trumble.pdf

  100. https://www.axios.com/2024/06/29/two-bidens-trump-debate-2024-president

  101. https://www.nature.com/articles/s41591-023-02729-2

  102. https://www.newyorker.com/news/annals-of-inquiry/how-to-find-a-missing-person-with-dementia

  103. https://www.nytimes.com/2017/07/14/opinion/sunday/alzheimers-cure-south-america.html

  104. https://www.nytimes.com/2023/05/20/health/elderly-move-managers.html

  105. https://www.science.org/content/article/potential-fabrication-research-images-threatens-key-theory-alzheimers-disease

  106. https://www.science.org/content/article/research-misconduct-finding-neuroscientist-eliezer-masliah-papers-under-suspicion

  107. https://www.science.org/content/blog-post/faked-beta-amyloid-data-what-does-it-mean

  108. https://www.science.org/content/blog-post/reduction-tau

  109. https://www.science.org/content/blog-post/saga-cassava

  110. https://www.science.org/content/blog-post/stroke-trial-concerns

  111. https://www.theatlantic.com/health/archive/2014/11/the-dutch-village-where-everyone-has-dementia/382195/

  112. https://www.theguardian.com/society/2023/feb/28/dinner-with-proust-how-alzheimers-caregivers-are-pulled-into-their-patients-worlds

  113. https://www.wired.com/story/parents-dementia-robots-warm-technology/

  114. Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial

  115. %252Fdoc%252Fpsychiatry%252Falzheimers%252F2023-gonzales.pdf.html

  116. The Vanishing Family: They all have a 50-50 chance of inheriting a cruel genetic mutation—which means disappearing into dementia in middle age. This is the story of what it’s like to live with those odds

  117. https%253A%252F%252Fwww.nytimes.com%252F2023%252F07%252F20%252Fmagazine%252Ffamily-genetics-frontotemporal-dementia.html.html

  118. Causal evidence that herpes zoster vaccination prevents a proportion of dementia cases

  119. https%253A%252F%252Fwww.medrxiv.org%252Fcontent%252F10.1101%252F2023.05.23.23290253.full.html

  120. New insights into the genetic etiology of Alzheimer’s disease and related dementias

  121. Najaf Amin

  122. Eric Boerwinkle

  123. Srdjan Djurovic

  124. Vilmundur Gudnason

  125. Lenore Joy Launer, Ph.D. Principal Investigators

  126. Markus Nöthen

  127. Dan Rujescu

  128. https://scholar.google.com/scholar?q=author%3A%22AG+Uitterlinden%22

  129. Psaty

  130. Mohammad Ikram Harvard Catalyst Profiles

  131. Professor Philippe Amouyel—University Hospital of Lille, JPND

  132. Ole A. Andreassen

  133. https%253A%252F%252Fwww.nature.com%252Farticles%252Fs41588-022-01024-z.html

  134. The viral hypothesis: how herpesviruses may contribute to Alzheimer’s disease

  135. https%253A%252F%252Fwww.nature.com%252Farticles%252Fs41380-021-01138-6.html